Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies

被引：30

作者：

Ochoa, Sebastian ^{[1
]}

Ding, Li ^{[1
]}

Kreuzburg, Samantha ^{[1
]}

Treat, Jennifer ^{[2
]}

Holland, Steven M. ^{[1
]}

Zerbe, Christa S. ^{[1
]}

机构：

[1] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA

[2] Med Sci & Comp, Rockville, MD USA

来源：

CLINICAL INFECTIOUS DISEASES | 2021年 / 72卷 / 12期

基金：

美国国家卫生研究院;

关键词：

daratumumab; mycobacteria; disseminated; interferon gamma; autoantibodies;

D O I：

10.1093/cid/ciaa1086

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patients with autoantibodies to interferon-gamma (IFN-gamma) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-gamma who had progressive infection, resulting in clinical and radiographic improvement.

引用

页码：2206 / 2208

页数：3

共 50 条

[41] Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma
Panaampon, Jutatip
Kariya, Ryusho
Okada, Seiji
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1017 - 1031
[42] Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma
Jutatip Panaampon
Ryusho Kariya
Seiji Okada
Cancer Immunology, Immunotherapy, 2022, 71 : 1017 - 1031
[43] Disseminated Talaromyces marneffei And Mycobacterium avium Infection Accompanied Sweet's Syndrome In A Patient With Anti-Interferon-γ Autoantibodies: A Case Report
Su, Shan-Shan
Zhang, Sheng-Nan
Ye, Jun-Ru
Xu, Ling-Na
Lin, Peng-Cheng
Xu, Han-Yan
Wu, Qing
Li, Yu-Ping
INFECTION AND DRUG RESISTANCE, 2019, 12 : 3189 - 3195
[44] Case report: serological testing interference of daratumumab (anti-CD38) therapy in multiple myeloma
Rabut, Elodie
Castro-Fernandez, Annabelle
Le Gall, Virginie
Meknache, Nihad
ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (03) : 351 - 355
[45] Disseminated Nontuberculous Mycobacterial Infection Associated With Acquired Immunodeficiency Due to Anti-Interferon γ Autoantibodies
Yerramilli, Arvind
Huang, G. Khai Lin
Griffin, David W. J.
Kong, Khai Lin
Muhi, Stephen
Muttucumaru, Ramona S.
Tio, Shio Yen
Chew, Su M.
Farah, Rashelle
Christie, Michael
Mahanty, Siddhartha
Schulz, Thomas R.
OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
[46] Case Report: Anti-interferon-γ autoantibodies in an adolescent with disseminated Talaromyces marneffei and mycobacterial co-infections
Li, Bingkun
Li, Tiantian
Huang, Qihua
Mo, Nanfang
He, Xiaojuan
Jiang, Zhiwen
Li, Xiuying
Huang, Xiaolu
Zhang, Xinyu
Cao, Cunwei
FRONTIERS IN PEDIATRICS, 2025, 13
[47] Talaromyces Marneffei and Nontuberculous Mycobacteria Co-Infection in HIV-Uninfected Patients with Anti-Interferon-γ Autoantibodies: A Multicentre Ambispective Cohort Study and Systematic Review
Zhang, J.
Qiu, Y.
Jie, H.
Dongmin, Q.
Guangnan, L.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[48] Anti-IFN-γ autoantibodies in disseminated nontuberculous mycobacterial infections
Patel, SY
Ding, L
Brown, MR
Lantz, L
Gay, T
Cohen, S
Martyak, LA
Kubak, B
Holland, SM
JOURNAL OF IMMUNOLOGY, 2005, 175 (07): : 4769 - 4776
[49] Daratumumab (anti-cd38) for Desensitization (des) of TreatmentResistant Highly Hla-Sensitized Esrd Patients
Vo, A. A.
Ammerman, N.
Bui, V.
Huang, E.
Zhang, X.
Shin, B.
Vescio, R.
Peng, A.
Najjar, R.
Meyers, C.
Lim, K.
Gillespie, M.
Badash, N.
Jordan, S. C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S376 - S376
[50] Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma
Tan, Carlyn Rose Co
Rueda, Colin
Shekarkhand, Tala
Derkach, Andriy
Korde, Neha
Maclachlan, Kylee
Hultcrantz, Malin
Hassoun, Hani
Mailankody, Sham
Shah, Urvi A.
Rajeeve, Sridevi
Lahoud, Oscar Boutros
Shah, Gunjan L.
Scordo, Michael
Chung, David J.
Landau, Heather Jolie
Giralt, Sergio
Usmani, Saad Zafar
Lesokhin, Alexander M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →